Abstract
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have